StockData
Lexaria Bioscience Corp. logo

Lexaria Bioscience Corp. (LEXX) stock

LEXXNasdaqPharmaceutical PreparationsFiscal year ends August 31
Financials through Q3 FY2026, quarter ended May 31, 2026Last filing: 10-Q on Jul 13, 2026Score 8/30
$4.28+0.10 (+2.39%)

Close on Nov 18, 2026Market cap $106.09MP/E –Yield –

Lexaria Bioscience revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Lexaria Bioscience's revenue for the twelve months ending May 31, 2026 was $194.00K, down 68.5% year over year. For fiscal 2025 it was $705.92K, up 52.0% from the year before. Over ten years it grew 47.3% a year on average. The highest annual figure on record is $722.74K in fiscal 2021.

Annual revenue

PeriodPeriod endValueChange
FY2025Aug 31, 2025$705.92K+52.0%
FY2024Aug 31, 2024$464.28K+105.2%
FY2023Aug 31, 2023$226.21K-11.4%
FY2022Aug 31, 2022$255.40K-64.7%
FY2021Aug 31, 2021$722.74K+129.6%
FY2020Aug 31, 2020$314.79K+41.4%
FY2019Aug 31, 2019$222.61K-48.6%
FY2018Aug 31, 2018$433.29K+580.9%
FY2017Aug 31, 2017$63.64K+56.3%
FY2016Aug 31, 2016$40.72K+177.0%
FY2015Aug 31, 2015$14.70K–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026May 31, 2026$0-100.0%
Q2 FY2026CQ1 2026Feb 28, 2026$20.00K-88.5%
Q1 FY2026CQ4 2025Nov 30, 2025$0-100.0%
Q4 FY2025CQ3 2025Aug 31, 2025$174.00K+107.1%
Q3 FY2025CQ2 2025May 31, 2025$174.00K+107.1%
Q2 FY2025CQ1 2025Feb 28, 2025$174.00K+20.0%
Q1 FY2025CQ4 2024Nov 30, 2024$183.92K+21.6%
Q4 FY2024CQ3 2024Aug 31, 2024$84.00K+173.3%
Q3 FY2024CQ2 2024May 31, 2024$84.00K+8.1%
Q2 FY2024CQ1 2024Feb 29, 2024$145.00K+624.1%
Q1 FY2024CQ4 2023Nov 30, 2023$151.28K+54.8%
Q4 FY2023CQ3 2023Aug 31, 2023$30.74K-72.3%
Q3 FY2023CQ2 2023May 31, 2023$77.71K-22.1%
Q2 FY2023CQ1 2023Feb 28, 2023$20.03K-34.7%
Q1 FY2023CQ4 2022Nov 30, 2022$97.74K+604.1%
Q4 FY2022CQ3 2022Aug 31, 2022$111.15K+258.3%
Q3 FY2022CQ2 2022May 31, 2022$99.72K-51.1%
Q2 FY2022CQ1 2022Feb 28, 2022$30.65K-84.0%
Q1 FY2022CQ4 2021Nov 30, 2021$13.88K-95.3%
Q4 FY2021CQ3 2021Aug 31, 2021$31.02K-51.5%
Q3 FY2021CQ2 2021May 31, 2021$204.06K+460.2%
Q2 FY2021CQ1 2021Feb 28, 2021$192.01K+411.3%
Q1 FY2021CQ4 2020Nov 30, 2020$295.66K+2761.6%
Q4 FY2020CQ3 2020Aug 31, 2020$63.99K-48.9%
Q3 FY2020CQ2 2020May 31, 2020$36.42K-39.2%
Q2 FY2020CQ1 2020Feb 29, 2020$37.55K+144.6%
Q1 FY2020CQ4 2019Nov 30, 2019$10.33K-53.5%
Q4 FY2019CQ3 2019Aug 31, 2019$125.12K+29.9%
Q3 FY2019CQ2 2019May 31, 2019$59.93K-57.3%
Q2 FY2019CQ1 2019Feb 28, 2019$15.35K-91.1%
Q1 FY2019CQ4 2018Nov 30, 2018$22.21K-9.8%
Q4 FY2018CQ3 2018Aug 31, 2018$96.35K+667.2%
Q3 FY2018CQ2 2018May 31, 2018$140.34K+379.7%
Q2 FY2018CQ1 2018Feb 28, 2018$171.96K+1264.5%
Q1 FY2018CQ4 2017Nov 30, 2017$24.64K+167.0%
Q4 FY2017CQ3 2017Aug 31, 2017$12.56K+46.7%
Q3 FY2017CQ2 2017May 31, 2017$29.25K–
Q2 FY2017CQ1 2017Feb 28, 2017$12.60K–
Q1 FY2017CQ4 2016Nov 30, 2016$9.23K–
Q4 FY2016CQ3 2016Aug 31, 2016$8.56K–

More Lexaria Bioscience figures

See a number that looks wrong?